Stallergenes Greer production back to full capacity after years of limited activity

An IT breakdown in 2015 has been the thorn in the side of Stallergenes Greer, which has only now regained full production capacity as it re-launches its series of allergy vaccines in Spain and Italy.

Photo: Stallergenes Greer/PR

French allergy firm Stallergenes Greer is finally back on track with production at its facilities in Southern Paris, it reports in a press release.

Back in 2015, Stallergenes was ordered to stop all production and distribution based at its factory in Antony by the French National Agency for the Safety of Medicines and Health Products (ANSM). Some products were recalled in France.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs